Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:dCTP)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001680 AN002739 Metabolome of NAFLD in high fat diet mouse model Liver Mouse Fatty liver disease Weill Cornell Medicine Abundance
ST002234 AN003644 A metabolic map of the DNA damage response identifies PRDX1 in nuclear ROS scavenging and aspartate synthesis Cultured cells Human DNA damage response CRG au
ST002123 AN003476 GCN2 regulates mitochondrial OXPHOS in HSPCs under proliferation conditions. Bone marrow Mouse Sun Yat-sen University AU
ST001850 AN002997 Unbiased LC-MS-based metabolomics analysis for both whole cell and mitochondria metabolites to gain an insight into the role of Tug1/PGC1 axis on metabolite profiles in podocytes Epithelial cells Mouse University of Texas MD Anderson Cancer Center AUC/ngDNA
ST001074 AN001756 Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1) Parasite Human Pennsylvania State University Average Peak Area
ST002178 AN003567 Age-independent Cardiac Protection by Pharmacological Activation of Beclin-1 During Endotoxemia and Its Association with Energy Metabolic Reprograming in Myocardium — A Targeted Metabolomics Study Heart Mouse Endotoxemia Loyola University Chicago Stritch School of Medicine count per second (cps)
ST002869 AN004702 Identifying Biodegradation Pathways of Cetrimonium Bromide (CTAB) Using Metagenome, Metatranscriptome, and Metabolome Tri-omics Integration Water Bacteria Environmental exposure Arizona State University counts per second
ST001188 AN001980 P. falciparum infected erythrocytes Cultured cells Plasmodium falciparum Malaria University of Melbourne ion count
ST002119 AN003468 Metabolomics analysis of zebrafish response to CID661578 treatment Larvae Zebrafish Diabetes North Carolina State University ion counts
ST000441 AN000692 Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways Plasmodium cells Plasmodium falciparum Malaria Pennsylvania State University log2 fold change vs untreated
ST001610 AN002644 Control (DMSO 0.1%; v/v) and 10 µM DRB18 treated A549 lung cancer cells in vitro for 48 hours Lung Human Cancer Ohio University Normalized abundances
ST001660 AN002711 Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Normalized and blank subtracted peak area
ST000133 AN000215 1H NMR Metabolomics Study of Metastatic Melanoma in C57BL/6J Mouse Spleen Spleen Mouse Cancer Pacific Northwest National Laboratory normalized conc. (uM/mg)
ST002467 AN004023 Nano-hijacked myeloid cells potentiate antitumor immunity and radiotherapy for glioblastoma Brain Mouse Cancer Northwestern University, Feinberg School of Medicine Normalized peak area
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002024 AN003294 Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002011 AN003277 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002011 AN003278 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003387 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003388 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003389 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003390 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002205 AN003608 Effect of Hira loss in the metabolic landscape of Fh1-deficient cells Cultured cells Mouse Cancer CECAD Research Center, University Hospital Cologne peak area
ST002218 AN003627 Effect of Hira loss in the metabolic landscape of Fh1-deficient cells Part 2 Cultured cells Mouse Cancer CECAD Research Center peak area
ST002221 AN003630 Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC Cultured cells Human Cancer CECAD Research Center peak area
ST002222 AN003631 Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC Cultured cells Human Cancer CECAD Research Center peak area
ST002224 AN003633 Intracellular metabolic profile of renal cells cultured in Plasmax Cultured cells Human Cancer CECAD Research Center peak area
ST002371 AN003866 High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages Macrophages Mouse Inflammation Wake Forest School of Medicine peak area
ST001232 AN002050 Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak area
ST001709 AN002784 SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition Cultured cells Human COVID-19 University of California, Los Angeles Peak area
ST002237 AN003650 Metabolomic analysis of brain cortex from neuronal specific Depdc5 knockout in fed and fasting state Brain Mouse Northwestern University Feinberg School of Medicine Peak area
ST002506 AN004128 Natural abundance of isotopic metabolite detection in mouse eye orgnaoids. Retina Mouse Northwestern University Peak area
ST002507 AN004129 Time-course analysis of C13 labeling in mouse eye organoids. Retina Mouse Northwestern University Peak area
ST001954 AN003179 A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s Ataxia Yeast cells Yeast Friedreichs Ataxia University of California, Los Angeles Peak Area
ST002709 AN004391 FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer Cultured cells Other Cancer University of California, Los Angeles Peak Area
ST002814 AN004706 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy Embryonic cells Mouse Diabetes University of California, Los Angeles Peak Area
ST002814 AN004706 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy Embryonic cells Mouse Hypoglycemia University of California, Los Angeles Peak Area
ST002814 AN004706 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy Embryonic cells Mouse Hypoglycemia; Diabetes University of California, Los Angeles Peak Area
ST002852 AN004673 MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer Prostate Mouse Cancer University of California, Los Angeles Peak Area
ST001170 AN001935 Timecourse on MCF-7 cells treated with different concentration of doxorubicin Cultured cells Human China Pharmaceutical University Peak area normalized
ST002499 AN004106 Metabolomics analysis of stress erythroid progenitors (Part 2) Stem cells Mouse Inflammation Pennsylvania State University peak area normalized to IS and cell number
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Adipose tissue Mouse University of Michigan Peak area (normalized to tissue mass)
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Blood Mouse University of Michigan Peak area (normalized to tissue mass)
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Heart Mouse University of Michigan Peak area (normalized to tissue mass)
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Liver Mouse University of Michigan Peak area (normalized to tissue mass)
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Muscle Mouse University of Michigan Peak area (normalized to tissue mass)
ST001149 AN001896 Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Area Post-Blank Subtraction
ST002115 AN003513 LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells Cultured cells Human University of Texas MD Anderson Cancer Center Peak area (top)
ST001937 AN003150 Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules Blood Human Cancer China Pharmaceutical University peak height
ST002412 AN003932 Metabolic effects of the protein kinase R Macrophages Mouse Hudson peak height
ST001274 AN002115 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST001276 AN002117 Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001549 AN002581 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University Peak intensity
ST001652 AN002699 Atypical Molecular Basis for Drug Resistance to Mitochondrial AQ: A Function Inhibitors in Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria U.S. Food & Drug Administration Peak intensity
ST002541 AN004187 Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 1) Yeast cells Yeast Life Sciences Institute, ZheJiang University Peak intensity
ST002542 AN004189 Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 2) Yeast cells Yeast Life Sciences Institute, ZheJiang University Peak intensity
ST002595 AN004267 MoTrPAC: Endurance exercise training study in young adult rats, Rat Gastrocnemius Powder - Targeted Nucleotides Gastrocnemius Rat Duke University pmol/mg of tissue
ST002601 AN004273 MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Targeted Nucleotides Heart Rat Duke University pmol/mg of tissue
ST002615 AN004287 MoTrPAC: Endurance exercise training study in young adult rats, Rat Liver Powder - Targeted Nucleotides Liver Rat Duke University pmol/mg of tissue
ST002625 AN004297 MoTrPAC: Endurance exercise training study in young adult rats, Rat White Adipose Powder - Targeted Nucleotides White adipose Rat Duke University pmol/mg of tissue
ST001769 AN002876 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part I) Cultured cells Human Boston Childrens Hospital ppm
ST001770 AN002877 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part II) Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001771 AN002878 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part III) Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001772 AN002879 Optimization of redox metabolite detection in mammalian cells (part II) Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST002584 AN004255 Metabolomics analysis of ALDH1L1-expressing HuH7 cell lines. Cultured cells Human Cancer Tohoku Medical and Pharmaceutical University relative area
ST001668 AN002721 D-Allulose effects on hepatic metabolomics profile in rodents Liver Rat Matsutani Chemical Industry Co., Ltd. Relative Area
ST001167 AN001930 Comprehensive Profiling by Non-targeted Stable Isotope Tracing Capillary Electrophoresis-Mass Spectrometry Cultured cells Human Cancer Dalian Institute Of Chemical Physics, Chinese Academy Of Sciences Relative intensity after normalization
ST002729 AN004423 Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. Muscle Mouse Diabetes Medical Institute of Bioregulation, Kyushu University relative peak area
ST002231 AN003641 Metabolomics Analysis of HOG-EV and HOG-R132H Cells with and without BAY 2402234 Treatment Cultured cells Human Cancer UT Southwestern Medical Center TIC-Corrected Peak Area
  logo